EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alistipes putredinis Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease in Rats via Gut Microbiota Remodeling and Inflammatory Suppression

Shuwei Zhang iD, Ruoshi Wang, Ruiqing Zhao iD, Yao Lu, Mingchao Xu, Xiaoying Lin, Ruiting Lan iD, Suping Zhang, Huijing Tang, Qianhua Fan, Jing Yang, Liyun Liu und 1 weitere

Nutrients · 16.06.2025 · 17 (12) · 2013

DOI: 10.3390/nu17122013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 16.06.2025. Verfasst von Shuwei Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prev…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Fatty Liver, Inflammation, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Units of Discovery of Unknown Bacteria and Function.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a highly prevalent chronic liver condition linked to obesity and metabolic imbalance. Alterations in the gut microbiota are increasingly recognized as contributors to its progression. Alistipes putredinis, a core member of the human gut microbiota, has been linked with metabolic health, but its functional role in MASLD remains unclear.

Methods

This study evaluated the potential of A. putredinis strain Ap77, isolated from the stool of a healthy adult, to mitigate MASLD-related alterations in a high-fat diet (HFD)-induced rat model. Animals were divided into normal chow (NC), HFD, and HFD plus Ap77 groups and received daily oral gavage of Ap77 or PBS for 8 weeks.

Results

Ap77 supplementation attenuated the body weight increase associated with high-fat diet consumption. It also reduced hepatic triglyceride levels and fat mass and improved liver histology. Transcriptomic analysis revealed suppression of inflammation-associated pathways. Correspondingly, the concentrations of IL-1β, IL-6, and TNF-α in both the liver and serum were reduced. Ap77 supplementation was associated with an increased abundance of health-associated bacterial genera, such as Lachnospiraceae UCG_010, Akkermansia, and Flavonifractor, as well as elevated serum levels of butyrate, indole-3-propionic acid, and indoleacrylic acid. Notably, correlation analysis revealed that Lachnospiraceae UCG_010 was positively associated with these metabolites.

Conclusions

A. putredinis Ap77 alleviates hepatic steatosis and inflammation in MASLD, potentially by reshaping gut microbiota and suppressing inflammation-related signaling pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeFatty LiverInflammationNon-alcoholic Fatty Liver DiseaseEubacterialesAnimalsMaleDiet, High-FatRatsLiverRats, Sprague-DawleyDisease Models, AnimalFeces

Stichwörter der Autor:innen

Alistipes putredinisMASLDbutyrategut microbiotaindole derivativesinflammation

Autor:innen und Institutionen

  • National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102…
  • School of Public Health, Nanjing Medical University, Nanjing 211166, China.
  • Department of Epidemiology and Statistics, School of Public Health, Hebei Medical University, Shijiazhuang 050010, China.
  • School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia.
  • Hebei Key Laboratory of Intractable Pathogens, Shijiazhuang Center for Disease Control and Prevention, Shijiazhuang 050011, China.

ORCID-Profile: Shuwei Zhang, Ruiqing Zhao, Ruiting Lan

Förderung

  • Research Units of Discovery of Unknown Bacteria and Function

Zitieren

APA

Zhang, S., Wang, R., Zhao, R., Lu, Y., Xu, M., Lin, X., Lan, R., Zhang, S., Tang, H., Fan, Q., Yang, J., Liu, L., & Xu, J. (2025). Alistipes putredinis Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease in Rats via Gut Microbiota Remodeling and Inflammatory Suppression. Nutrients, 17(12), 2013. https://doi.org/10.3390/nu17122013

Vancouver

Zhang S, Wang R, Zhao R, Lu Y, Xu M, Lin X, et al. Alistipes putredinis Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease in Rats via Gut Microbiota Remodeling and Inflammatory Suppression. Nutrients. 2025;17(12):2013. doi:10.3390/nu17122013

BibTeX
@article{Zhang2025,
  author = {Zhang, Shuwei and Wang, Ruoshi and Zhao, Ruiqing and Lu, Yao and Xu, Mingchao and Lin, Xiaoying and Lan, Ruiting and Zhang, Suping and Tang, Huijing and Fan, Qianhua and Yang, Jing and Liu, Liyun and Xu, Jianguo},
  title = {Alistipes putredinis Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease in Rats via Gut Microbiota Remodeling and Inflammatory Suppression},
  journal = {Nutrients},
  year = {2025},
  volume = {17},
  number = {12},
  pages = {2013},
  doi = {10.3390/nu17122013}
}
Kostenlos starten →